Main Street Financial Solutions’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,499
Closed -$340K 545
2024
Q4
$340K Sell
3,499
-921
-21% -$98.2K 0.03% 357
2024
Q3
$508K Buy
4,420
+1,703
+63% +$193K 0.05% 306
2024
Q2
$289K Hold
2,717
0.03% 437
2024
Q1
$263K Buy
2,717
+44
+2% +$4.51K 0.03% 437
2023
Q4
$270K Buy
2,673
+155
+6% +$15K 0.03% 386
2023
Q3
$256K Buy
2,518
+220
+10% +$22.3K 0.04% 376
2023
Q2
$232K Sell
2,298
-119
-5% -$11.9K 0.03% 407
2023
Q1
$222K Sell
2,417
-86
-3% -$7.51K 0.03% 410
2022
Q4
$227K Buy
+2,503
New +$211K 0.04% 395

Other funds holding NVS

Main Street Financial Solutions's NVS Position: Q1 2025 in Review

Main Street Financial Solutions sold out of Novartis (NVS) in Q1 2025, closing a stake of 3,499 shares — an estimated $340K sold.

Main Street Financial Solutions first reported a position in NVS in Q4 2022 and held it in 9 quarters. The position peaked at $508K in Q3 2024. 1,356 funds tracked by Wall St. Rank hold NVS as of Q1 2025.

  • Main Street Financial Solutions reported no remaining Novartis position as of Q1 2025 after selling out during the quarter.
  • Main Street Financial Solutions sold 3,499 Novartis shares in Q1 2025, an estimated $340K.
  • Main Street Financial Solutions first reported a position in Novartis in Q4 2022 and held it in 9 quarters.
  • Main Street Financial Solutions's Novartis position peaked at $508K in Q3 2024.
  • 1,356 funds tracked by Wall St. Rank held Novartis as of Q1 2025.

Based on Main Street Financial Solutions's 13F filing for Q1 2025, filed 8 May 2025.